The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

✍ Scribed by Gini, B.; Zanca, C.; Guo, D.; Matsutani, T.; Masui, K.; Ikegami, S.; Yang, H.; Nathanson, D.; Villa, G. R.; Shackelford, D.; Zhu, S.; Tanaka, K.; Babic, I.; Akhavan, D.; Lin, K.; Assuncao, A.; Gu, Y.; Bonetti, B.; Mortensen, D. S.; Xu, S.; Raymon, H. K.; Cavenee, W. K.; Furnari, F. B.; James, C. D.; Kroemer, G.; Heath, J. R.; Hege, K.; Chopra, R.; Cloughesy, T. F.; Mischel, P. S.

• Book ID: 121346812
• Publisher: American Association for Cancer Research
• Year: 2013
• Tongue: English
• Weight: 836 KB
• Volume: 19
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.CCR-13-0527